Brokerages Set Trupanion, Inc. (NASDAQ:TRUP) PT at $46.60

Shares of Trupanion, Inc. (NASDAQ:TRUP - Get Free Report) have earned an average recommendation of "Moderate Buy" from the seven research firms that are presently covering the company, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold recommendation, four have given a buy recommendation and one has issued a strong buy recommendation on the company. The average 12 month target price among brokers that have updated their coverage on the stock in the last year is $46.60.

TRUP has been the subject of a number of recent research reports. Stifel Nicolaus cut their price objective on Trupanion from $44.00 to $41.00 and set a "hold" rating for the company in a research report on Thursday, February 20th. Piper Sandler decreased their price target on Trupanion from $57.00 to $52.00 and set an "overweight" rating for the company in a research report on Thursday, February 20th.

Insider Activity

In related news, CEO Margaret Tooth sold 4,000 shares of the stock in a transaction dated Monday, April 21st. The stock was sold at an average price of $33.34, for a total value of $133,360.00. Following the completion of the sale, the chief executive officer now directly owns 118,784 shares of the company's stock, valued at approximately $3,960,258.56. This represents a 3.26 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, COO John R. Gallagher sold 3,100 shares of the firm's stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $32.99, for a total value of $102,269.00. Following the sale, the chief operating officer now owns 25,549 shares of the company's stock, valued at $842,861.51. The trade was a 10.82 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 33,792 shares of company stock worth $1,122,802 over the last quarter. Corporate insiders own 5.50% of the company's stock.

Institutional Investors Weigh In On Trupanion

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Amundi increased its stake in shares of Trupanion by 193.2% in the fourth quarter. Amundi now owns 16,828 shares of the financial services provider's stock worth $784,000 after acquiring an additional 11,088 shares during the last quarter. Barclays PLC increased its position in Trupanion by 259.2% in the 3rd quarter. Barclays PLC now owns 65,498 shares of the financial services provider's stock worth $2,750,000 after purchasing an additional 47,262 shares during the last quarter. Vanguard Group Inc. raised its stake in shares of Trupanion by 1.3% during the 4th quarter. Vanguard Group Inc. now owns 3,596,725 shares of the financial services provider's stock worth $173,362,000 after purchasing an additional 45,653 shares in the last quarter. Wealthfront Advisers LLC acquired a new stake in shares of Trupanion during the 4th quarter valued at about $845,000. Finally, Illinois Municipal Retirement Fund bought a new stake in shares of Trupanion in the 4th quarter valued at approximately $834,000.

Trupanion Price Performance

NASDAQ:TRUP traded up $0.70 during midday trading on Friday, hitting $35.68. 551,753 shares of the stock were exchanged, compared to its average volume of 653,470. The business has a 50-day moving average price of $35.90 and a two-hundred day moving average price of $45.38. The company has a current ratio of 1.71, a quick ratio of 1.66 and a debt-to-equity ratio of 0.39. The company has a market capitalization of $1.52 billion, a price-to-earnings ratio of -155.13, a P/E/G ratio of 6.02 and a beta of 1.66. Trupanion has a one year low of $19.69 and a one year high of $57.90.

Trupanion (NASDAQ:TRUP - Get Free Report) last posted its quarterly earnings data on Wednesday, February 19th. The financial services provider reported $0.04 earnings per share for the quarter, missing the consensus estimate of $0.06 by ($0.02). Trupanion had a negative net margin of 0.75% and a negative return on equity of 3.08%. The business had revenue of $337.31 million for the quarter, compared to the consensus estimate of $335.41 million. Sell-side analysts predict that Trupanion will post 0.13 EPS for the current year.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.